Stratos Wealth Partners, Ltd. Horizon Therapeutics Public LTD CO Transaction History

Stratos Wealth Partners, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$79.4 - $116.36 $65,187 - $95,531	-821 Reduced 17.49%	3,873 $309,000
Q1 2022 Apr 26, 2022	SELL	$86.42 - $109.81 $75,531 - $95,973	-874 Reduced 15.7%	4,694 $494,000
Q4 2021 Jan 14, 2022	BUY	$98.56 - $119.91 $3,745 - $4,556	38 Added 0.69%	5,568 $600,000
Q3 2021 Oct 19, 2021	BUY	$91.91 - $110.37 $14,613 - $17,548	159 Added 2.96%	5,530 $606,000
Q2 2021 Jul 19, 2021	SELL	$86.24 - $95.92 $105,730 - $117,597	-1,226 Reduced 18.58%	5,371 $503,000
Q1 2021 Apr 27, 2021	SELL	$71.83 - $95.48 $45,899 - $61,011	-639 Reduced 8.83%	6,597 $607,000
Q4 2020 Jan 29, 2021	SELL	$67.0 - $84.39 $160,264 - $201,860	-2,392 Reduced 24.84%	7,236 $529,000
Q3 2020 Oct 29, 2020	BUY	$55.23 - $79.93 $531,754 - $769,566	9,628 New	9,628 $748,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.